Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Sarcoma 2Gynecologic 2Endocrine 1CNS 1

Conditions

Vipoma 1Stomach Neoplasms 1Somatostatinoma 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Neoplasms 1Insulinoma 1Glucagonoma 1Gastrointestinal Stromal Tumors 1Gastrinoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Islet Cell 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 5Docetaxel 4ulixertinib 2Trastuzumab 2Radiotherapy 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Irinotecan 2Fluorodeoxyglucose F18 2Carboplatin 2Capecitabine 2Bevacizumab 2trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1temsirolimus 1tanespimycin 1spartalizumab 1sonidegib 1sargramostim 1sapanisertib 1relatlimab 1regorafenib 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Floxuridine × CNS × Clear all
NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

National Cancer Institute (NCI)

Phase 1 Completed
CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡